Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-064253

Chief Financial Officer sold 10,000 shares at an average $34.98 ($349,800)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Cohen Chad M Chief Financial Officer 2021-11-09 Option exercise +5,000 $7.27 $36,350 26,604 D
Cohen Chad M Chief Financial Officer 2021-11-09 Sale −5,000 $36.03 $180,150 21,604 D
Cohen Chad M Chief Financial Officer 2021-11-10 Option exercise +5,000 $7.27 $36,350 26,604 D
Cohen Chad M Chief Financial Officer 2021-11-10 Sale −5,000 $33.93 $169,650 21,604 D
Derivatives
Cohen Chad M Chief Financial Officer 2021-11-09 Option exercise · Stock Option (Right to Buy) −5,000 95,000 D
Cohen Chad M Chief Financial Officer 2021-11-10 Option exercise · Stock Option (Right to Buy) −5,000 90,000 D
Open-market sales · 10,000 sh · avg $34.98 · $349,800
Loading xslF345X03/doc4.xml…